Crossmark

RIMOXCLAMIN: New therapeutic regimen for Hansen’s Disease cure based on effective sensitivity recovery

Crossref DOI link: https://doi.org/10.1016/j.bjid.2025.104539

Published Print: 2025-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Frade, Marco Andrey Cipriani https://orcid.org/0000-0003-2700-5971
Albertino, Gustavo Sartori https://orcid.org/0000-0003-0728-7828
Lima, Filipe Rocha https://orcid.org/0000-0001-7629-4963
de Paula, Natália Aparecida https://orcid.org/0000-0002-3744-8947
Cinto, Fabiana Aparecida Correa

Perecin, Fernanda Cruz

Westin, Andrezza

Junior, Wilson Marques

Lugão, Helena Barbosa https://orcid.org/0000-0003-1623-7443
License Information

Text and Data Mining valid from 2025-07-01

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-05-02
More Information

This article is maintained by: Elsevier

Article Title: RIMOXCLAMIN: New therapeutic regimen for Hansen’s Disease cure based on effective sensitivity recovery

Journal Title: The Brazilian Journal of Infectious Diseases

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjid.2025.104539

Content Type: article

Copyright: © 2025 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U.